Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
XCUR compared with LLY: revenue, margins and what each company keeps, and the suppliers and customers both name
XCUR
Exicure, Inc.
Change
Mkt cap
Revenue
Revenue
LLY
ELI Lilly & Co
Change
Mkt cap
Revenue
Revenue
vs
Compare
XCUR
Exicure, Inc.
vs
LLY
ELI Lilly & Co
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Supply-chain overlap
Desk
News
Calendar
Saved
Search
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only XCUR
1
—
Bluejay Therapeutics
unlisted
customer
Shared
0
No shared counterparties.
Only LLY
29
MCK
McKesson
customer
CAH
Cardinal Health
customer
VEEV
Veeva Systems
supplier
UTHR
United Therapeutics
customer
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
25 more · LLY chain
›
XCUR
Exicure, Inc.
Change
0.87
▼
−12.37%
Mkt cap
$5.8M
Revenue
$500,000
Q1 FY24
Revenue
—
LLY
ELI Lilly & Co
Change
1,360.21
▼
−0.33%
Regular session
Nov 6 '26
Mkt cap
$1.2T
Revenue
$24.4B
Q3 FY26
Revenue
$65.2B
FY25
vs
Compare
Regular session
Nov 6 '26
XCUR
Exicure, Inc.
vs
LLY
ELI Lilly & Co
0.87
▼
−12.37%
Price
1,360.21
▼
−0.33%
$5.8M
Mkt cap
$1.2T
Q1 FY24
$500,000
Revenue
$24.4B
Q3 FY26
—
Revenue
$65.2B
FY25
Change
Change
XCUR
0.87
▼
−12.37%
vs
LLY
1,360.21
▼
−0.33%
Regular session
Nov 6 '26